See also this year's filing and all EDGAR filings for this company.
PDF Report 0001829635_2023_Transcode_Therapeutics_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001829635, Transcode Therapeutics Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 7,379,405 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 208,581 |
3 | remainder_Assets | 0 |
4 | LiabilitiesCurrent | 4,347,290 |
5 | LiabilitiesNoncurrent | 0 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 8,433,448 |
9 | ResearchAndDevelopmentExpense | 10,232,366 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | 1,100,846 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 7,587,986 |
1 | Liabilities | 4,347,290 |
2 | Expenses | 18,665,814 |
3 | Revenues | 0 |
4 | StockholdersEquity | 3,240,696 |
5 | NetIncome | -17,564,968 |
6 | ComprehensiveNetIncome | -17,564,968 |
7 | BaseVar | 15,850,968 |
8 | EconomicCapitalRatio | -2.01 |